Funder
National Cancer Institute
Fogarty International Center
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Reference88 articles.
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. https://doi.org/10.3322/caac.21660.
2. Colorectal Cancer Statistics | How common is colorectal cancer? https://www.cancer.org/cancer/colon-rectal-cancer/about/key-statistics.html. Accessed 1 Mar 2021
3. Tsilimigras DI, Ntanasis-Stathopoulos I, Bagante F, Moris D, Cloyd J, Spartalis E, et al. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: a systematic review of the current evidence. Surg Oncol. 2018;27:280–8. https://doi.org/10.1016/j.suronc.2018.05.012.
4. Colon Cancer (Version 2.2021). In: National Comprehensive Cancer Network. https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf. Accessed 2 Mar 2021
5. •• Tosi F, Magni E, Amatu A, Mauri G, Bencardino K, Truini M, et al. Effect of KRAS and BRAF mutations on survival of metastatic colorectal cancer after liver resection: a systematic review and meta-analysis. Clin Colorectal Cancer. 2017;16:e153–63. https://doi.org/10.1016/j.clcc.2017.01.004 This article is the most recent systematic review and meta-analysis concerning the prognostic value of KRAS and BRAF mutations in patients undergoing CRLM resection.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献